chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: A lot of pain in the side of her neck and it kind of goes towards the head and down the collar bones; Vaccination site pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (A lot of pain in the side of her neck and it kind of goes towards the head and down the collar bones) and VACCINATION SITE PAIN (Vaccination site pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included COLECALCIFEROL (VITAMIN D 3), CALCIUM and GLUCOSAMINE, METHYLSULFONYLMETHANE (MSM & GLUCOSAMINE) for an unknown indication, Blood pressure and reflux medication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (A lot of pain in the side of her neck and it kind of goes towards the head and down the collar bones) and VACCINATION SITE PAIN (Vaccination site pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Neck pain, at an unspecified dose and frequency. At the time of the report, NECK PAIN (A lot of pain in the side of her neck and it kind of goes towards the head and down the collar bones) had not resolved and VACCINATION SITE PAIN (Vaccination site pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site reaction, Vaccination site swelling, Vaccination site warmth
Clinical narrative: arm turned red and sorta swelled up a little bit and got kinda hot; some kind of reaction; arm turned red and sorta swelled up a little bit and got kinda hot; arm turned red and sorta swelled up a little bit and got kinda hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm turned red and sorta swelled up a little bit and got kinda hot), VACCINATION SITE REACTION (some kind of reaction), VACCINATION SITE SWELLING (arm turned red and sorta swelled up a little bit and got kinda hot) and VACCINATION SITE ERYTHEMA (arm turned red and sorta swelled up a little bit and got kinda hot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE WARMTH (arm turned red and sorta swelled up a little bit and got kinda hot), VACCINATION SITE REACTION (some kind of reaction), VACCINATION SITE SWELLING (arm turned red and sorta swelled up a little bit and got kinda hot) and VACCINATION SITE ERYTHEMA (arm turned red and sorta swelled up a little bit and got kinda hot). At the time of the report, VACCINATION SITE WARMTH (arm turned red and sorta swelled up a little bit and got kinda hot), VACCINATION SITE REACTION (some kind of reaction), VACCINATION SITE SWELLING (arm turned red and sorta swelled up a little bit and got kinda hot) and VACCINATION SITE ERYTHEMA (arm turned red and sorta swelled up a little bit and got kinda hot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported using multiple medications (unspecified) and 3 Tylenol(paracetamol) every day regularly. Patient placed damp cloths on the affected area as treatment.   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: A telephone contact was attempted and the consumer denied email information.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Extreme pressure in her head, which gave her a headache; A spontaneous report was received from a consumer concerning a female patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events extreme pressure in her head, which gave her a headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 29 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  On 29 Jan 2021, 50 minutes later the patient experienced an extreme pressure in her head, which gave her a headache. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of event, extreme pressure in her head, which gave her a headache was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event,, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in my fingers, hands and wrist; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling in my fingers, hands and wrist) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Dec-2020,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (tingling in my fingers, hands and wrist). At the time of the report, PARAESTHESIA (tingling in my fingers, hands and wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site erythema, Vaccination site induration
Clinical narrative: Hard to the touch Injection Site; Red area came back bigger (2 quarter size) Injection Site; Red spot quarter size on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hard to the touch Injection Site), INJECTION SITE ERYTHEMA (Red spot quarter size on the injection site) and VACCINATION SITE ERYTHEMA (Red area came back bigger (2 quarter size) Injection Site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Red spot quarter size on the injection site). On 31-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard to the touch Injection Site) and VACCINATION SITE ERYTHEMA (Red area came back bigger (2 quarter size) Injection Site). On 24-Jan-2021, INJECTION SITE ERYTHEMA (Red spot quarter size on the injection site) had resolved with sequelae. At the time of the report, VACCINATION SITE INDURATION (Hard to the touch Injection Site) and VACCINATION SITE ERYTHEMA (Red area came back bigger (2 quarter size) Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product administration interrupted, Vaccination site erythema, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: did not take second dose, suppsoed to take it today; big itch hive that started a pink spot; Itchy; pink spot; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE URTICARIA (big itch hive that started a pink spot), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (pink spot) and PRODUCT ADMINISTRATION INTERRUPTED (did not take second dose, suppsoed to take it today) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unk) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (big itch hive that started a pink spot), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (pink spot). On 28-Jan-2021, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (did not take second dose, suppsoed to take it today). On 26-Jan-2021, VACCINATION SITE URTICARIA (big itch hive that started a pink spot), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (pink spot) had resolved. On 28-Jan-2021, PRODUCT ADMINISTRATION INTERRUPTED (did not take second dose, suppsoed to take it today) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       No relevant concomitant medications were reported. Treatment details included Zyrtec and Steroid cream Patient was scheduled to take second dose 28jan2021 but did not take it as she wanted  to see her allergist next week Thursday before she can decide whether to take it or not.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Aches all over her body), HEADACHE (Mild Headache) and PYREXIA (Fever 101 Farenheit) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced MYALGIA (Aches all over her body), HEADACHE (Mild Headache) and PYREXIA (Fever 101 Farenheit). The patient was treated with PARACETAMOL (TYLENOL) on 27-Jan-2021 for Fever and Headache, at an unspecified dose and frequency. On 28-Jan-2021, MYALGIA (Aches all over her body) and PYREXIA (Fever 101 Farenheit) had resolved. At the time of the report, HEADACHE (Mild Headache) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Body temperature: 101 (High) 101 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: injection site red and spreading; injection site itching that is spreading; injection site hot; injection site itchy; injection site red; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE PRURITUS (injection site itchy), ERYTHEMA (injection site red and spreading) and PRURITUS (injection site itching that is spreading) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE WARMTH (injection site hot) and VACCINATION SITE PRURITUS (injection site itchy). On 01-Feb-2021, the patient experienced ERYTHEMA (injection site red and spreading) and PRURITUS (injection site itching that is spreading). At the time of the report, VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE WARMTH (injection site hot) and VACCINATION SITE PRURITUS (injection site itchy) had resolved and ERYTHEMA (injection site red and spreading) and PRURITUS (injection site itching that is spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: Patient called back to report, initial delayed reaction went away, but came back on 01Feb2021 again and is spreading., vaccine lot NO. was added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: little pink points around the site and down upper arm, like multiple injections; 5 days after shot she had extremely itchy at the injection site; the injection site little red; some soreness at the injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (5 days after shot she had extremely itchy at the injection site), VACCINATION SITE RASH (little pink points around the site and down upper arm, like multiple injections), VACCINATION SITE PAIN (some soreness at the injection site) and VACCINATION SITE ERYTHEMA (the injection site little red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concomitant products included big complexfor hair growth for Abnormal hair growth, LEVOTHYROXINE SODIUM (THYROXINE), METFORMIN, ATORVASTATIN CALCIUM (LIPITOR), CORTISONE and VITAMINS NOS for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (some soreness at the injection site). On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (5 days after shot she had extremely itchy at the injection site) and VACCINATION SITE ERYTHEMA (the injection site little red). On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (little pink points around the site and down upper arm, like multiple injections). At the time of the report, VACCINATION SITE PRURITUS (5 days after shot she had extremely itchy at the injection site), VACCINATION SITE RASH (little pink points around the site and down upper arm, like multiple injections), VACCINATION SITE PAIN (some soreness at the injection site) and VACCINATION SITE ERYTHEMA (the injection site little red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Rash on the injection arm; A spontaneous report was received from a Consumer concerning a 25-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rash on the injection arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Jan 2021, prior to the onset of the event the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced Rash on the injection arm.  Treatment details included OTC Cream.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event, rash on the injection arm was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Injection site induration, Pruritus, Tenderness
Clinical narrative: Itching; arm was covered in a large red circle; hard; Reddish circle; tender; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Reddish circle), TENDERNESS (tender), PRURITUS (Itching), ERYTHEMA (arm was covered in a large red circle) and INJECTION SITE INDURATION (hard) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.  No treatment information was reported.  On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Reddish circle) and TENDERNESS (tender). On 05-Feb-2021, the patient experienced PRURITUS (Itching), ERYTHEMA (arm was covered in a large red circle) and INJECTION SITE INDURATION (hard). On 02-Feb-2021, INJECTION SITE ERYTHEMA (Reddish circle) had resolved. At the time of the report, TENDERNESS (tender), PRURITUS (Itching), ERYTHEMA (arm was covered in a large red circle) and INJECTION SITE INDURATION (hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Reddish circle), TENDERNESS (tender), PRURITUS (Itching), ERYTHEMA (arm was covered in a large red circle) and INJECTION SITE INDURATION (hard) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to Dose #2. On 29-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Reddish circle) and TENDERNESS (tender). On 05-Feb-2021, the patient experienced PRURITUS (Itching), ERYTHEMA (arm was covered in a large red circle) and INJECTION SITE INDURATION (hard). On 02-Feb-2021, INJECTION SITE ERYTHEMA (Reddish circle) had resolved. At the time of the report, TENDERNESS (tender), PRURITUS (Itching), ERYTHEMA (arm was covered in a large red circle) and INJECTION SITE INDURATION (hard) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: No specific follow-up information recorded.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: No specific follow-up information recorded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: bad case of diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (bad case of diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included high blood pressure medication for Blood pressure high, IBUPROFEN (ADVIL [IBUPROFEN]) from 07-Feb-2021 to an unknown date for an unknown indication.    On 07-Feb-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021 at 7:00 AM, the patient experienced DIARRHOEA (bad case of diarrhea). At the time of the report, DIARRHOEA (bad case of diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (positive for Covid-19) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (positive for Covid-19). At the time of the report, COVID-19 (positive for Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, COVID-19: (Positive) Positive for Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Head hurts; Sore arm; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (Head hurts) and VACCINATION SITE PAIN (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (Head hurts) and VACCINATION SITE PAIN (Sore arm). At the time of the report, HEADACHE (Head hurts) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Headache, Heart rate
Clinical narrative: tachycardia up to 130; tightness in chest ,  discomfort in chest; low pulse ox of 94; out of breath; fever of 101.2; nausea; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (tachycardia up to 130), CHEST DISCOMFORT (tightness in chest ,  discomfort in chest), OXYGEN SATURATION ABNORMAL (low pulse ox of 94), DYSPNOEA (out of breath) and PYREXIA (fever of 101.2) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthmatic. Concomitant products included INHALER for Asthma.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced TACHYCARDIA (tachycardia up to 130), CHEST DISCOMFORT (tightness in chest ,  discomfort in chest), OXYGEN SATURATION ABNORMAL (low pulse ox of 94), DYSPNOEA (out of breath), PYREXIA (fever of 101.2), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, TACHYCARDIA (tachycardia up to 130) and OXYGEN SATURATION ABNORMAL (low pulse ox of 94) had resolved and CHEST DISCOMFORT (tightness in chest ,  discomfort in chest), DYSPNOEA (out of breath), PYREXIA (fever of 101.2), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Heart rate: 130 (High) tachycardia up to 130. On 04-Feb-2021, Oxygen saturation: 94 Low. On 04-Feb-2021, Pyrexia: 101.2 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided., patient reported feeling like using inhaler because she is asthmatic, but it is unknown if she used it.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oxygen saturation, Oxygen saturation abnormal, Pyrexia, Tachycardia
Clinical narrative: tachycardia up to 130; tightness in chest ,  discomfort in chest; low pulse ox of 94; out of breath; fever of 101.2; nausea; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (tachycardia up to 130), CHEST DISCOMFORT (tightness in chest ,  discomfort in chest), OXYGEN SATURATION ABNORMAL (low pulse ox of 94), DYSPNOEA (out of breath) and PYREXIA (fever of 101.2) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthmatic. Concomitant products included INHALER for Asthma.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced TACHYCARDIA (tachycardia up to 130), CHEST DISCOMFORT (tightness in chest ,  discomfort in chest), OXYGEN SATURATION ABNORMAL (low pulse ox of 94), DYSPNOEA (out of breath), PYREXIA (fever of 101.2), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, TACHYCARDIA (tachycardia up to 130) and OXYGEN SATURATION ABNORMAL (low pulse ox of 94) had resolved and CHEST DISCOMFORT (tightness in chest ,  discomfort in chest), DYSPNOEA (out of breath), PYREXIA (fever of 101.2), NAUSEA (nausea), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Heart rate: 130 (High) tachycardia up to 130. On 04-Feb-2021, Oxygen saturation: 94 Low. On 04-Feb-2021, Pyrexia: 101.2 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided., patient reported feeling like using inhaler because she is asthmatic, but it is unknown if she used it.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Colitis, Nausea, Purpura, Pyrexia
Clinical narrative: Colitis; Purpura rash, red part in lower back; Fever; Chills; Nausea; This spontaneous case was reported by an other health care professional and describes the occurrence of COLITIS (Colitis), PURPURA (Purpura rash, red part in lower back), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COLITIS (Colitis), PURPURA (Purpura rash, red part in lower back), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, COLITIS (Colitis), PURPURA (Purpura rash, red part in lower back), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: Live follow up received: Email address of reporter was added.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: sweats; Could not dress; weakness, Could not dress herself; fever of 102 F; lymph nodes under her arm/collar bone on the same side of the injection became swollen; chills; Headache; body fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not dress), ASTHENIA (weakness, Could not dress herself), PYREXIA (fever of 102 F) and LYMPHADENOPATHY (lymph nodes under her arm/collar bone on the same side of the injection became swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Was on ventilator for Covid-  March 2020) in March 2020. Concurrent medical conditions included Drug allergy (Allergy to NSAIDs) and Asthma. Concomitant products included LEVOTHYROXINE, FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) and ALBUTEROL SULFATE for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced HYPERHIDROSIS (sweats), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not dress), ASTHENIA (weakness, Could not dress herself), PYREXIA (fever of 102 F), LYMPHADENOPATHY (lymph nodes under her arm/collar bone on the same side of the injection became swollen), CHILLS (chills), HEADACHE (Headache) and FATIGUE (body fatigue). At the time of the report, HYPERHIDROSIS (sweats), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not dress), ASTHENIA (weakness, Could not dress herself), PYREXIA (fever of 102 F), LYMPHADENOPATHY (lymph nodes under her arm/collar bone on the same side of the injection became swollen), CHILLS (chills), HEADACHE (Headache) and FATIGUE (body fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, Body temperature: 102 f (High) 102 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Loss of personal independence in daily activities, Lymphadenopathy, Pyrexia
Clinical narrative: sweats; Could not dress; weakness, Could not dress herself; fever of 102 F; lymph nodes under her arm/collar bone on the same side of the injection became swollen; chills; Headache; body fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not dress), ASTHENIA (weakness, Could not dress herself), PYREXIA (fever of 102 F) and LYMPHADENOPATHY (lymph nodes under her arm/collar bone on the same side of the injection became swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Was on ventilator for Covid-  March 2020) in March 2020. Concurrent medical conditions included Drug allergy (Allergy to NSAIDs) and Asthma. Concomitant products included LEVOTHYROXINE, FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) and ALBUTEROL SULFATE for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced HYPERHIDROSIS (sweats), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not dress), ASTHENIA (weakness, Could not dress herself), PYREXIA (fever of 102 F), LYMPHADENOPATHY (lymph nodes under her arm/collar bone on the same side of the injection became swollen), CHILLS (chills), HEADACHE (Headache) and FATIGUE (body fatigue). At the time of the report, HYPERHIDROSIS (sweats), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not dress), ASTHENIA (weakness, Could not dress herself), PYREXIA (fever of 102 F), LYMPHADENOPATHY (lymph nodes under her arm/collar bone on the same side of the injection became swollen), CHILLS (chills), HEADACHE (Headache) and FATIGUE (body fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, Body temperature: 102 f (High) 102 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Somnolence, Vaccination site pain
Clinical narrative: Just want to sleep; Aching; Upper part of my left arm is pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SOMNOLENCE (Just want to sleep), MYALGIA (Aching) and VACCINATION SITE PAIN (Upper part of my left arm is pain) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0736759) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021 at 2:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Just want to sleep), MYALGIA (Aching) and VACCINATION SITE PAIN (Upper part of my left arm is pain). At the time of the report, SOMNOLENCE (Just want to sleep), MYALGIA (Aching) and VACCINATION SITE PAIN (Upper part of my left arm is pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient reported that , her doctor suggested to take  650mg over the counter medication(unknown)   Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: Follow up information was received on 29 Jan 2021; no new information added in the follow up.
Age: 82.0
Sex: U
Vaccine: COVID19
Symptoms: Cough, Muscle spasms, Pain, Pharyngeal swelling, Vomiting
Clinical narrative: Terrible pain; Throat swollen; cough; muscle spasm neck moving to front; muscle spasium leg, back, arm left side,neck moving to front; vomit; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasium leg, back, arm left side,neck moving to front), PHARYNGEAL SWELLING (Throat swollen), MUSCLE SPASMS (muscle spasm neck moving to front), COUGH (cough) and PAIN (Terrible pain) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Central vision loss and Sleep apnoea (c pap). Concurrent medical conditions included Drug allergy (to opioids).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VOMITING (vomit). On 25-Jan-2021, the patient experienced MUSCLE SPASMS (muscle spasium leg, back, arm left side,neck moving to front). On 26-Jan-2021, the patient experienced MUSCLE SPASMS (muscle spasm neck moving to front). On 29-Jan-2021, the patient experienced PHARYNGEAL SWELLING (Throat swollen) and COUGH (cough). On an unknown date, the patient experienced PAIN (Terrible pain). On 24-Jan-2021, VOMITING (vomit) outcome was unknown. On 27-Jan-2021, MUSCLE SPASMS (muscle spasium leg, back, arm left side,neck moving to front) outcome was unknown. On 29-Jan-2021, MUSCLE SPASMS (muscle spasm neck moving to front) outcome was unknown. At the time of the report, PHARYNGEAL SWELLING (Throat swollen), COUGH (cough) and PAIN (Terrible pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. It was reported R/T: (Oxy 98 percent) Treatment :Applied heating pad   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: New event was added
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Headache, Injection site pain
Clinical narrative: back hurts; arm hurt and was sore; light headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (arm hurt and was sore), HEADACHE (light headache) and BACK PAIN (back hurts) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE PAIN (arm hurt and was sore) and HEADACHE (light headache). On 08-Feb-2021, the patient experienced BACK PAIN (back hurts). At the time of the report, INJECTION SITE PAIN (arm hurt and was sore), HEADACHE (light headache) and BACK PAIN (back hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Received TCR patients email address was  provided.He also stated that he never had back  pain following the vaccine.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Dyspnoea, Illness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (has lost of sense taste), ANOSMIA (has lost of sense smell), ILLNESS (does not feel good), COVID-19 (symptoms of covid,) and DYSPNOEA (breathing off) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes since 01-Jan-2012. Concomitant products included METFORMIN from 01-Jan-2012 to an unknown date for Diabetes, TAMSULOSIN from 01-Jan-2019 to an unknown date for Enlarged prostate, EMPAGLIFLOZIN (JARDIANCE) from 01-Jan-2013 to an unknown date for HbA1C, GABAPENTIN from 01-Jan-2010 to an unknown date for Neuropathy, TIZANIDINE from 01-Jan-2020 to an unknown date for Sprain and Cervical pain. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (symptoms of covid,) and DYSPNOEA (breathing off). On 27-Jan-2021, the patient experienced AGEUSIA (has lost of sense taste), ANOSMIA (has lost of sense smell) and ILLNESS (does not feel good). In March 2021, COVID-19 (symptoms of covid,) had not resolved. At the time of the report, AGEUSIA (has lost of sense taste), ANOSMIA (has lost of sense smell) and ILLNESS (does not feel good) outcome was unknown and DYSPNOEA (breathing off) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test: positive (Positive) POSITIVE. Patient reported in follow up, he went for a COVID-19 test in the same week as experiencing COVID symptoms, which was positive and he is still suffering from breathing difficulties(breathing off) at the time of report. No treatment medication was provided. Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Medical history, patient details, concomitant medications and therapy details were updated. added event breathing off.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (has lost of sense taste), ANOSMIA (has lost of sense smell), ILLNESS (does not feel good), COVID-19 (symptoms of covid,) and DYSPNOEA (breathing off) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 010M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes since 01-Jan-2012. Concomitant products included METFORMIN from 01-Jan-2012 to an unknown date for Diabetes, TAMSULOSIN from 01-Jan-2019 to an unknown date for Enlarged prostate, EMPAGLIFLOZIN (JARDIANCE) from 01-Jan-2013 to an unknown date for HbA1C, GABAPENTIN from 01-Jan-2010 to an unknown date for Neuropathy, TIZANIDINE from 01-Jan-2020 to an unknown date for Sprain and Cervical pain. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jan-2021, the patient experienced COVID-19 (symptoms of covid,) and DYSPNOEA (breathing off). On 27-Jan-2021, the patient experienced AGEUSIA (has lost of sense taste), ANOSMIA (has lost of sense smell) and ILLNESS (does not feel good). In March 2021, COVID-19 (symptoms of covid,) had not resolved. At the time of the report, AGEUSIA (has lost of sense taste), ANOSMIA (has lost of sense smell) and ILLNESS (does not feel good) outcome was unknown and DYSPNOEA (breathing off) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test: positive (Positive) POSITIVE. Patient reported in follow up, he went for a COVID-19 test in the same week as experiencing COVID symptoms, which was positive and he is still suffering from breathing difficulties(breathing off) at the time of report. No treatment medication was provided. Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Medical history, patient details, concomitant medications and therapy details were updated. added event breathing off.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain). At the time of the report, VACCINATION SITE PAIN (pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Myalgia, Vaccination site erythema, Vaccination site rash
Clinical narrative: pain in her back; Rash; shoulder pain, left knee pian; Red; swelling rash; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in her back), VACCINATION SITE RASH (Rash), ARTHRALGIA (shoulder pain, left knee pian), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (swelling rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in her back), VACCINATION SITE RASH (Rash), ARTHRALGIA (shoulder pain, left knee pian), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (swelling rash) and MYALGIA (Body ache). At the time of the report, BACK PAIN (pain in her back), VACCINATION SITE RASH (Rash), ARTHRALGIA (shoulder pain, left knee pian), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (swelling rash) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: pain in her back; Rash; shoulder pain, left knee pian; Red; swelling rash; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in her back), VACCINATION SITE RASH (Rash), ARTHRALGIA (shoulder pain, left knee pian), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (swelling rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in her back), VACCINATION SITE RASH (Rash), ARTHRALGIA (shoulder pain, left knee pian), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (swelling rash) and MYALGIA (Body ache). At the time of the report, BACK PAIN (pain in her back), VACCINATION SITE RASH (Rash), ARTHRALGIA (shoulder pain, left knee pian), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (swelling rash) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact